BOT.AX
Price:
$0.455
Market Cap:
$827.02M
Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that ...[Read more]
Industry
Biotechnology
IPO Date
1988-01-31
Stock Exchange
ASX
Ticker
BOT.AX
According to Botanix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is -18.00%. This represents a change of 7.40% compared to the average of -16.76% of the last 4 quarters.
The mean historical ROE of Botanix Pharmaceuticals Limited over the last ten years is -336.23%. The current -18.00% ROE has changed -94.65% with respect to the historical average. Over the past ten years (40 quarters), BOT.AX's ROE was at its highest in in the December 2015 quarter at 101.83%. The ROE was at its lowest in in the June 2019 quarter at -2090.02%.
Average
-336.23%
Median
-69.20%
Minimum
-2769.64%
Maximum
-12.76%
Discovering the peaks and valleys of Botanix Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.00%
Maximum Annual ROE = -12.76%
Minimum Annual Increase = -97.44%
Minimum Annual ROE = -2769.64%
Year | ROE | Change |
---|---|---|
2024 | -12.76% | -68.02% |
2023 | -39.88% | -75.31% |
2022 | -161.57% | 908.00% |
2021 | -16.03% | -77.35% |
2020 | -70.78% | -97.44% |
2019 | -2769.64% | 4.00% |
2018 | -67.62% | -22.98% |
2017 | -87.79% | 63.46% |
2016 | -53.71% | -34.94% |
2015 | -82.55% | 63.75% |
The current ROE of Botanix Pharmaceuticals Limited (BOT.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-71.40%
5-year avg
-60.20%
10-year avg
-336.23%
Botanix Pharmaceuticals Limited’s ROE is less than MGC Pharmaceuticals Limited (562.83%), less than Zelira Therapeutics Limited (1.07%), greater than Creso Pharma Limited (-130.99%), greater than Cann Group Limited (-159.56%), greater than Althea Group Holdings Limited (-414.04%),
Company | ROE | Market cap |
---|---|---|
562.83% | $18.42M | |
1.07% | $7.15M | |
-130.99% | $23.11M | |
-159.56% | $20.90M | |
-414.04% | $13.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Botanix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Botanix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Botanix Pharmaceuticals Limited's ROE?
How is the ROE calculated for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the highest ROE for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the 3-year average ROE for Botanix Pharmaceuticals Limited (BOT.AX)?
What is the 5-year average ROE for Botanix Pharmaceuticals Limited (BOT.AX)?
How does the current ROE for Botanix Pharmaceuticals Limited (BOT.AX) compare to its historical average?